Pulmonary Function Testing Systems Market Registers 6.6% CAGR as Adoption of Advanced Lung Testing Accelerates

United States of America - December 30, 2025 - According to The Insight Partners, the pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028. The pulmonary function testing systems market is steadily emerging as a cornerstone of modern respiratory diagnostics, driven by the rising global burden of lung-related disorders and a growing emphasis on early, accurate disease detection. Across healthcare settings, clinicians are increasingly relying on pulmonary function testing systems to gain deeper insights into lung performance, enabling timely diagnosis, improved disease monitoring, and more personalized treatment strategies.

As respiratory health moves higher on public health agendas worldwide, pulmonary function testing systems are becoming indispensable tools in hospitals, diagnostic laboratories, and specialty pulmonary clinics. These systems provide non-invasive, reliable assessments of airflow, lung volumes, and gas exchange, supporting the management of both chronic and acute respiratory conditions.

Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPRE00017822/?utm_source=OpenPR&utm_medium=10826

Market Overview: Strengthening the Foundation of Respiratory Care

The pulmonary function testing systems market continues to evolve alongside advancements in medical technology and changing clinical practices. These systems play a critical role in evaluating lung health, supporting physicians in diagnosing asthma, chronic obstructive pulmonary disorder, restrictive lung disease, and unexplained chronic shortness of breath.

Healthcare providers are increasingly prioritizing diagnostic accuracy and workflow efficiency, which has elevated demand for both cart-based PFT systems and stationery PFT systems. As healthcare systems globally move toward preventive and value-based care models, pulmonary function testing systems are being integrated earlier in patient care pathways, reinforcing their long-term relevance.

Latest Market News and Industry Developments

Recent industry activity within the pulmonary function testing systems market highlights a strong shift toward digitalization and smart diagnostics. Manufacturers are focusing on advanced software platforms that enhance data accuracy, automate quality checks, and simplify result interpretation for clinicians. Integration with electronic health records has become a key differentiator, enabling seamless patient data management and longitudinal tracking of lung function.

Another significant development is the growing focus on user-friendly designs and patient comfort. Compact and ergonomically designed systems are improving patient compliance, while remote monitoring capabilities are expanding access to pulmonary testing beyond traditional hospital settings. These innovations reflect the market's response to evolving clinical and operational demands.

Market Trends and Growth Drivers

Several interconnected trends are shaping the growth trajectory of the pulmonary function testing systems market:
• Increasing prevalence of chronic respiratory diseases
• Growing awareness of early diagnosis and preventive lung screening
• Rising adoption of technologically advanced diagnostic equipment
• Expansion of outpatient and specialty pulmonary care facilities
• Demand for standardized and reproducible testing outcomes
Together, these drivers are reinforcing the role of pulmonary function testing systems as essential diagnostic assets in respiratory medicine.

Market Size, Share, Trends, Analysis, and Forecast by 2031

• The pulmonary function testing systems market is expected to maintain steady expansion, supported by consistent demand from hospitals and diagnostic centers.
• Market share is increasingly influenced by technological differentiation, particularly software-driven analytics and system integration capabilities.
• Trends indicate growing preference for systems that offer multi-test functionality within a single platform.
• Market analysis suggests sustained investment in respiratory diagnostics as healthcare systems adapt to aging populations and environmental health challenges.
• The market forecast through 2031 points toward continued adoption across both developed and emerging regions, driven by clinical need and technological progress.

Segmentation Analysis: Meeting Diverse Clinical Needs

By Type:
Cart-based PFT systems dominate high-volume clinical environments due to their comprehensive testing capabilities, while stationary PFT systems are gaining adoption in specialized pulmonary laboratories for consistent and standardized assessments.

By Test Type:
Spirometry remains the most widely used test, supported by lung volume measurement, gas exchange testing, maximum voluntary ventilation, and oxygen titration testing. This comprehensive testing portfolio enables clinicians to assess respiratory function from multiple perspectives.

By Component:
Hardware forms the foundation of pulmonary function testing systems, while software solutions are increasingly critical for data interpretation, reporting, and compliance. Services such as maintenance, calibration, and training add long-term operational value.

By Application:
The pulmonary function testing systems market supports a broad range of clinical applications, including chronic obstructive pulmonary disorder, asthma, restrictive lung disease, and chronic shortness of breath evaluation.

Global and Regional Market Analysis

Globally, the pulmonary function testing systems market is experiencing sustained growth as respiratory health becomes a central focus of healthcare planning. Developed regions benefit from established diagnostic protocols, advanced infrastructure, and higher awareness levels. These factors contribute to consistent system upgrades and technology adoption.

Regionally, North America remains a leading market due to strong emphasis on preventive diagnostics and advanced healthcare delivery models. Europe follows closely, supported by standardized respiratory testing guidelines and expanding pulmonary care programs. The Asia Pacific region is witnessing accelerated growth as healthcare access improves and awareness of respiratory diseases rises. Meanwhile, Latin America and the Middle East & Africa are gradually strengthening their market presence through expanding diagnostic capabilities and public health initiatives.

Competitive Landscape and Key Market Players

The pulmonary function testing systems market is characterized by active competition and continuous innovation. Leading companies are focusing on product enhancements, strategic partnerships, and geographic expansion to strengthen their market position. Prominent players operating in the market include SCHILLER, COSMED srl, MGC Diagnostics Corporation, Ganshoran Medizin Electronic, ndd Medical Technologies, Morgan Scientific Inc., Pulm One Advanced Medical Devices Ltd, CHEST M.I., Inc., and Vyaire Medical, Inc.

These companies are investing in research and development to introduce next-generation pulmonary function testing systems that align with evolving clinical requirements and regulatory standards.

Purchasing This Report? Click Here At - https://www.theinsightpartners.com/buy/TIPRE00017822/?utm_source=OpenPR&utm_medium=10826

If you have any special requirements about this Pulmonary Function Testing Systems Market report, please let us know and we can provide custom report.

Outlook: A Resilient and Future-Ready Market

Looking ahead, the pulmonary function testing systems market is well-positioned for long-term growth as respiratory diagnostics continue to gain prominence across healthcare ecosystems. Ongoing technological innovation, rising disease awareness, and expanding access to diagnostic services are expected to sustain market momentum through 2031.

As healthcare providers seek reliable, patient-centric diagnostic solutions, pulmonary function testing systems will remain integral to improving respiratory outcomes and supporting proactive, data-driven care worldwide.

Related Reports

• PFT Systems Market - https://www.theinsightpartners.com/reports/pft-systems-market
• Respiratory Ventilator Tester Market - https://www.theinsightpartners.com/reports/respiratory-ventilator-tester-market
• Spirometer Market - https://www.theinsightpartners.com/reports/spirometers-market
• In Vitro Lung Models Market - https://www.theinsightpartners.com/reports/in-vitro-lung-model-market
• Spirometer Transducers Market - https://www.theinsightpartners.com/reports/spirometer-transducers-market

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in: 日本 | 한국어 | Français | لعربية< | 中文 | Italiano | Español | Deutsch

About The Insight Partners

The Insight Partners is among the leading market research and consulting firms in the world. We take pride in delivering exclusive reports along with sophisticated strategic and tactical insights into the industry. Reports are generated through a combination of primary and secondary research, solely aimed at giving our clientele a knowledge-based insight into the market and domain. This is done to assist clients in making wiser business decisions. A holistic perspective in every study undertaken forms an integral part of our research methodology and makes the report unique and reliable.

This release was published on openPR.